Efficacy and safety of colesevelam for the treatment of bile acid diarrhoea: A double-blind, randomised, placebo-controlled, phase 4 clinical trial
insert needle at a 4590 angle into subcutaneous tissue (angle depends on needle length and body fat) [20][21]
Before committing to a provider, look into whether they offer free consultations, compounded versions of the medication, and options for virtual or in-person care.
Safety, Side Effects, and Medical Supervision Considerations Both semaglutide and tirzepatide carry similar safety profiles, with nausea, vomiting, and constipation as common early side effects that typically resolve within 2-4 weeks
Studies have shown that participants using Semaglutide alongside lifestyle changes lost an average of 14.9% of their body weight over 68 weeks, compared to just 2.4% for those on a placebo
Do not use for more than 2 days